Fourpath Capital Management
TMO icon

Fourpath Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Fourpath Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.92M Sell
8,776
-216
-2% -$128K 0.77% 30
2026
Q2 		$4.51M Sell
8,992
-168
-2% -$80.6K 0.59% 44
2026
Q1 		$4.5M Sell
9,160
-247
-3% -$134K 0.65% 42
2025
Q4 		$5.45M Sell
9,407
-69
-0.7% -$39K 0.75% 35
2025
Q3 		$4.6M Sell
9,476
-1
-0% -$465 0.65% 38
2025
Q2 		$3.84M Sell
9,477
-142
-1% -$59.4K 0.6% 45
2025
Q1 		$4.79M Sell
9,619
-114
-1% -$61.7K 0.83% 32
2024
Q4 		$5.06M Sell
9,733
-207
-2% -$114K 0.94% 33
2024
Q3 		$6.15M Buy
9,940
+9,435
+1,868% +$5.59M 1.13% 24
2024
Q2 		$279K Sell
505
-29
-5% -$16.6K 0.21% 100
2024
Q1 		$310K Sell
534
-3
-0.6% -$1.68K 0.22% 92
2023
Q4 		$285K Buy
537
+72
+15% +$34.8K 0.19% 96
2023
Q3 		$235K Buy
465
+52
+13% +$27.7K 0.18% 104
2023
Q2 		$215K Sell
413
-23
-5% -$12.4K 0.26% 91
2023
Q1 		$251K Sell
436
-45
-9% -$25.4K 0.18% 107
2022
Q4 		$265K Sell
481
-70
-13% -$37.1K 0.19% 103
2022
Q3 		$279K Sell
551
-80
-13% -$44.8K 0.19% 99
2022
Q2 		$343K Sell
631
-28
-4% -$15.4K 0.21% 97
2022
Q1 		$389K Sell
659
-48
-7% -$27.6K 0.15% 109
2021
Q4 		$472K Buy
+707
New +$441K 0.18% 95

Other funds holding TMO

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
James Hambro & Partners
James Hambro & Partners London, United Kingdom $2.87B AUM 19.92% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Egerton Capital (UK)
Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Fourpath Capital Management's TMO Position: Q3 2026 in Review

Fourpath Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 2.4% in Q3 2026, selling an estimated $128K and leaving 8,776 shares worth $5.92M. The position accounts for 0.77% of the portfolio, ranked #30.

Fourpath Capital Management first reported a position in TMO in Q4 2021 and has held it in 20 quarters since. The position peaked at $6.15M in Q3 2024. 598 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Fourpath Capital Management held 8,776 shares of Thermo Fisher Scientific worth $5.92M as of Q3 2026.
  • Fourpath Capital Management sold 216 Thermo Fisher Scientific shares in Q3 2026, an estimated $128K.
  • Thermo Fisher Scientific made up 0.77% of Fourpath Capital Management's portfolio in Q3 2026, its #30 holding.
  • Fourpath Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 20 quarters since.
  • Fourpath Capital Management's Thermo Fisher Scientific position peaked at $6.15M in Q3 2024.
  • 598 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.